Company Info
Phone(908) 842-0100
Year Established
2022
Ticker
LSTA
Exchange
NASDAQ
Contacts
David J. Mazzo, PhDPresident & CEO
Kristen K. Buck, MD
CMO
Gregory S. Berkin
CIO
James Nisco
VP, Finance
Tariq Imam
VP, Business Development
Company Description
Lisata Therapeutics, a Kuva Labs company, formerly Caladrius/Cend Therapeutics, Neostem, Corniche Group and Phase III Medical, is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease.